The Treatment of Non-Hodgkin's Lymphomas

Immunophenotype evaluation of Non-Hodgkin’s lymphomas

Background: Non-Hodgkin’s lymphoma (NHLs) is known as a heterogeneous group of malignant lymphoproliferative disorders. NHLs are classified into B cell and T cell types. Immunophenotypical assessment of the biopsy specimens can help diagnose NHLs.    Methods: In this study, 77 patients with B cell and T cell lymphoma were selected from Shahid Sadoghi hospital during 2010 to 2...

Pediatric Non Hodgkin’s Lymphomas

Viral-related RNA in Hodgkins' disease and other human lymphomas.

Molecular hybridization with radioactively labeled DNA complementary to the RNA of the Rauscher leukemia virus was used to probe for homologous RNA in human lymphomas. 22 of 32 specimens contained RNA possessing homology to the RNA of the mouse leukemia virus, but not to that of the unrelated viruses causing mammary tumors in mice or myeloblastosis in chickens. Normal adult and fetal tissues fa...

Non-Hodgkins Lymphoma presenting as Garcin’s Syndrome

An 80 year old man presented with a twelve month history of progressive multiple unilateral cranial nerve palsies. A gadolinium enhanced MRI scan of his head and neck was performed. This showed an extra-axial enhancing lesion, which enveloped the hemi-mandible at the level of the left inferior alveolar nerve, and a dumbbell shaped lesion within the cerebellopontine angle. An incisional biopsy w...

Hodgkins lymphoma: treatment and prognosis

Supported in part by a grant provided by “IASIS” a non-profit organization raising funds for Research in Leukemias, Lymphomas and related disorders come. AAS I/IIA are definitely non-advanced for most study groups. Non-advanced stages are further classified as “early” or “early favourable” and “intermediate” or “early unfavourable” according to the presence of adverse features. Table 1 summariz...